These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3864785)

  • 1. High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva.
    Vree TB; Baars AM; Wijnands WJ
    J Chromatogr; 1985 Oct; 343(2):449-54. PubMed ID: 3864785
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the antibacterial trovafloxacin by differential-pulse adsorptive stripping voltammetry.
    Vílchez JL; Taoufiki J; Araujo L; Navalón A
    J Pharm Biomed Anal; 2003 Mar; 31(3):465-71. PubMed ID: 12615233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of enoxacin in elderly patients.
    Wise R; Baker SL; Misra M; Griggs D
    J Antimicrob Chemother; 1987 Mar; 19(3):343-50. PubMed ID: 3471751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography.
    Zhai S; Korrapati MR; Wei X; Muppalla S; Vestal RE
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):372-6. PubMed ID: 7581914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a new antibacterial agent (AT-2266) and its metabolites in plasma and urine by high-performance liquid chromatography.
    Nakamura R; Yamaguchi T; Sekine Y; Hashimoto M
    J Chromatogr; 1983 Dec; 278(2):321-8. PubMed ID: 6583207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of enoxacin.
    Wise R; Lockley R; Dent J; Webberly M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone and monoacetyldapsone determined in serum and saliva by a sensitive high-performance liquid chromatographic method with a single extraction step.
    Pieters FA; Vincken BJ; Zuidema J
    J Chromatogr; 1987 Nov; 422():322-7. PubMed ID: 3437021
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enoxacin: characteristics and determination by HPLC].
    Marini D; Pollino G
    Boll Chim Farm; 1987 Aug; 126(8):336-41. PubMed ID: 3482782
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
    Hamel B; Audran M; Costa P; Bressolle F
    J Chromatogr A; 1998 Jul; 812(1-2):369-79. PubMed ID: 9691332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of enoxacin in human serum and prostatic tissue by HPLC.
    White LO; Bowyer HM; McMullin CH; Desai K
    J Antimicrob Chemother; 1988 Apr; 21(4):512-3. PubMed ID: 3163995
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline.
    Zhai S; Wei X; Parker BM; Kunze KL; Vestal RE
    Ther Drug Monit; 1996 Dec; 18(6):666-71. PubMed ID: 8946663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone penetration of enoxacin in patients with and without osteomyelitis.
    Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
    Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
    García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
    Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
    J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.